Exceptional response and multisystem autoimmune-like toxicities associated with the same T cell clone in a patient with uveal melanoma treated with immune checkpoint inhibitors. [electronic resource]
Producer: 20200331Description: 61 p. digitalISSN:- 2051-1426
- Antineoplastic Agents, Immunological -- adverse effects
- Bone Neoplasms -- drug therapy
- CTLA-4 Antigen -- antagonists & inhibitors
- Fatal Outcome
- Female
- Humans
- Ipilimumab -- adverse effects
- Liver Neoplasms -- drug therapy
- Lung Neoplasms -- drug therapy
- Melanoma -- drug therapy
- Middle Aged
- Nivolumab -- adverse effects
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Retinal Diseases -- chemically induced
- T-Lymphocytes -- immunology
- Uveal Neoplasms -- drug therapy
- Uveomeningoencephalitic Syndrome -- chemically induced
- Uveal Melanoma
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.